News

HERA Trial Shows Better Overall Survival With Trastuzumab

Publish date: August 1, 2006
PDF Download

 

Trial sponsor Roche markets trastuzumab internationally and has a majority interest in Genentech Inc., which markets the drug in the United States.

Pages

Recommended Reading

Menopausal Hormones May Bring On Depression
MDedge Internal Medicine
Women Entering Menopause Have Increased Risk of Major Depression
MDedge Internal Medicine
In Elective Cesarean, Honor Patient Choice : A panel of experts says maternal requests should not be encouraged or discouraged.
MDedge Internal Medicine
Initiating DMPA Without Delay Reduces Unintended Pregnancies
MDedge Internal Medicine
For Late-Pregnancy Choking Victim, Use Heimlich Maneuver on the Floor
MDedge Internal Medicine
Valproic Acid
MDedge Internal Medicine
Two Deaths After Mifepristone Medical Abortion Prompt FDA to Issue Advisory
MDedge Internal Medicine
Four Criteria Signal Presence of Ovarian Cancer
MDedge Internal Medicine
GI Agents: Part II
MDedge Internal Medicine
Weighing New Evidence on SSRI Use
MDedge Internal Medicine